StonvexLoading…
StonvexStonvexStonvexCore line items from HR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.70M | $28.21M | $20.26M | $13.37M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-56.00K | $-246.07M | $-260.46M | $-202.72M |
EPS (Diluted) | $0.00 | $-0.71 | $-0.75 | $-0.58 |
Total Assets | $9.15B | $9.21B | $9.86B | $10.24B |
Total Liabilities | $4.65B | $4.53B | $5.11B | $5.35B |
Cash & Equivalents | $26.23M | $26.17M | $43.34M | $25.51M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 346.53M | 351.60M | 351.60M | 351.57M |